Monday, August 01, 2022 7:19:52 AM
08/24/2018 Reverse 1:100
03/27/2020 Reverse 1:10000
AS increase expected early 2022 - Assume Unlimited
Mid April. 400k. ( following 10000:1 RS was 4 billion)
Mid May. 2.3 Million
Mid June 17.2 Million
Mid July 152 million (Restated 196 Million)
Mid August 446 million
End September 843 Million
October 1.504 Billion
November 1.889 Billion
December 2.326 Billion
Dilution stopped following a deal with the toxic dilutors
Feb 2021 OS has continued to rise, and is now 2.9 billion
Mar 2021 3.229 Billion
Apr 2021 3.545 Billion
May / June No Change
July 2021 3.853 Billion
Aug 2021 3.967 Billion
Sep 2021 4.03 Billion
Oct 2021 4.33 Billion
Nov 2021 4.38 Billion
Dec 2021 4.43 Billion
Jan 2022 4.63 Billion
Feb 2022 4.73 Billion
March 2022 - No Change
April 2022 4.83 Billion
May 2022 4.86 Billion
June 2022 4.94 Billion
July 2022 4.99 Billion ( AS of 5 Billion hit )
Since Dilution was claimed to have stopped in December 2020 another 2.6 Billion shares added to the OS
More Toxic debt taken on in September 2021 ( $20 million, with another $10 million cleared )
Recent AITX News
- Shares Moving Up For AI SAAS Firm on News of an Initial Order • AllPennyStocks.com • 04/11/2024 03:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:04:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:08:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 11:01:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:09:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:07:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 11:05:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 11:02:46 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/07/2024 05:15:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 11:05:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 11:02:25 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2024 09:21:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:03:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 11:01:53 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/19/2024 09:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 11:04:22 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 08:59:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:05:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 11:02:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 11:03:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 11:03:10 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/12/2023 08:58:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM